The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4 Wenhu ChenLiqiang HuChen Huang Preclinical study Open access 11 July 2023 Pages: 353 - 366
Is de-escalation of treatment by omission of radiotherapy associated with fear of cancer recurrence in women with early breast cancer? An exploratory study Lesley StaffordMichelle SinclairG. Bruce Mann Preclinical study Open access 22 July 2023 Pages: 367 - 376
Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer Tom Wei-Wu ChenWen HsiaoYen-Shen Lu Clinical trial Open access 21 June 2023 Pages: 377 - 385
Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy Lubna N. ChaudharyJulie M. JornsHallgeir Rui Clinical trial 17 July 2023 Pages: 387 - 396
Analysis of prognosis in different subtypes of invasive lobular carcinoma using the Japanese National Cancer Database-Breast Cancer Registry Yayoi AdachiSota AsagaMasakazu Toi Clinical trial 21 July 2023 Pages: 397 - 408
Phase II trial of biweekly administration with eribulin after three cycles of induction therapy in hormone receptor-positive, HER2-negative metastatic breast cancer (JACCRO BC-03) Kokoro KobayashiNorikazu MasudaYoshinori Ito Clinical trial 22 July 2023 Pages: 409 - 415
Prediction of nipple involvement in breast cancer after neoadjuvant chemotherapy: Should we rely on breast MRI to preserve the nipple? M. Umit UgurluOnur BugdayciBahadir M. Gulluoglu Clinical trial 25 July 2023 Pages: 417 - 424
Effects of letrozole on serum estradiol and estrone in postmenopausal breast cancer patients and tolerability of treatment: a prospective trial using a highly sensitive LC–MS/MS (liquid chromatography–tandem mass spectrometry) method for estrogen measurement Mária FaltinováLeena VehmanenJohanna Mattson Clinical trial Open access 25 July 2023 Pages: 425 - 435
The dynamics of HER2-low expression during breast cancer progression Sarah AndersonBrooke Baxter BartowShi Wei Epidemiology 12 July 2023 Pages: 437 - 446
Differential distribution of actual and surrogate oncotype DX recurrence scores in breast cancer patients by age, menopausal status, race, and body mass index Anas MohamedLinnea T. OlssonJoseph Geradts Epidemiology 15 July 2023 Pages: 447 - 460
Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system Sarah KnerrBoya GuoKatrina A. B. Goddard Epidemiology 20 July 2023 Pages: 461 - 470
The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy M. E.C. WaaijerA. A. LemijN. A. de Glas Epidemiology Open access 21 July 2023 Pages: 471 - 478
Sexual health in long-term breast cancer survivors: a comparison with female population controls from the HUNT study Solveig K. SmedslandKathrine F. VandraasKristin V. Reinertsen Epidemiology Open access 25 July 2023 Pages: 479 - 488
Treatments for breast cancer in men: late effects and impact on quality of life Jorge AvilaBeth HerrickJosé Pablo Leone Original Laboratory Investigation 07 July 2023 Pages: 489 - 498
SGLT1 as an adverse prognostic factor in invasive ductal carcinoma of the breast Satoko TsunokakeErina IwabuchiTakashi Suzuki Original Laboratory Investigation 13 July 2023 Pages: 499 - 513
FN1 mediated activation of aspartate metabolism promotes the progression of triple-negative and luminal a breast cancer Chen ChenLeiguang YeZhigao Li Original Laboratory Investigation 17 July 2023 Pages: 515 - 533
Oestrogen receptor low positive breast cancer: associations with prognosis Anette H. SkjervoldMarit VallaAnna M. Bofin Original Laboratory Investigation Open access 18 July 2023 Pages: 535 - 545
Clinical characteristics and treatment outcomes of invasive ductal and lobular carcinoma: analyses of 54,832 taiwan cancer registry index cases Bo-Fang ChenYi-Fang TsaiChi-Cheng Huang Original Laboratory Investigation 20 July 2023 Pages: 547 - 560
Dimethyl fumarate inhibits ZNF217 and can be beneficial in a subset of estrogen receptor positive breast cancers Tanu SharmaYuanjin ZhangIrida Kastrati Original Laboratory Investigation 21 July 2023 Pages: 561 - 570
Plasma apolipoprotein M predicts overall survival in metastatic breast cancer patients Axel MuendleinChristine HeinzleThomas Decker Original Laboratory Investigation 25 July 2023 Pages: 571 - 576
